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Recently two parturients with Eisenmenger’s syndrome underwent caesarean section at our hospital. They were managed by a
multidisciplinary team during their perioperative period. The caesarean sections were uneventfully performed, one under general
anaesthesia and one with epidural anaesthesia, with delivery of two newborns with satisfactory Apgar scores. One patient died in
the post-partum period, and the other did well. We discuss the anaesthetic considerations in managing these high-risk patients.
1.Introduction
D u r i n gan o r m a lp r e g n a n c y ,p a r t u r i e n t su n d e r g od r a m a t i c
physiological changes in multiple organ systems. Changes
in the cardiovascular system include decreased systemic
vascular resistance (SVR), increased blood volume, and
increased cardiac output (CO) secondary to increased heart
rate (HR) and stroke volume (SV). Cardiac disease is a major
cause of maternal death, and approximately 25% of maternal
cardiacdeathsinthelast30yearshavebeenduetocongenital
heart disease [1]. Eisenmenger’s syndrome is classiﬁed in
the high-risk category, with potentially severe cardiac and
neonatal complications [2].
Eisenmenger’s syndrome is characterized by right-to-
left or bidirectional shunting from severe pulmonary hyper-
tension. Despite advances in medicine, the perioperative
maternal mortality remains unacceptably high (estimated
at 30%–50%) [3]. The anaesthetic management of cae-
sarean section for parturients with Eisenmenger’s syndrome
remains an anaesthetic challenge. We present our anaesthetic
management of caesarean section of two recent cases. The
reporting of these cases was approved by the Institutional
R e v i e wB o a r do fT o n g j iM e d i c a lC o l l e g e .
2. Case Presentation
2.1.Case1. A19-year-oldprimigravida(weight60kg,height
160cm) at 33-week gestation was referred to our hospital
for VSD with Eisenmenger’s syndrome. A cardiac murmur
was noted in childhood, but no diagnosis or treatment was
performed. She had no symptoms until she developed fre-
quent and severe nausea and vomiting during her pregnancy.
Nine days prior to admission, she developed severe fatigue,
progressive cough, and shortness of breath. Past medical
history was signiﬁcant only for penicillin allergy. Physical
examination revealed cyanosis and clubbing of her ﬁngers.
Vital signs were temperature 36.8◦C, heart rate (HR) 84
beats·min−1, respiratory rate (RR) 24 breaths·min−1, blood
pressure (BP) 140/95mmHg, and oxygen saturation by pulse
oximetry (SpO2) 74% on 6L·min−1 of oxygen by facemask.
Auscultation revealed a loud P2 and a grade 4/6 systolic
murmur at the pulmonary area. There were jugular venous
distention and mild lower extremity edema. Arterial blood
gas analysis on room air demonstrated pH 7.41, PaO2
38mmHg, PaCO2 33mmHg, and SaO2 72%. Laboratory
tests included hemoglobin (Hb) 13g·dL−1, hematocrit (Hct)
43%, platelets 15 × 109·L−1, alanine aminotransferase (ALT)
267U·L−1, aspartate aminotransferase (AST) 230U·L−1,
albumin 2.96g·dL−1, D-dimer 1585ng·mL−1,a n dﬁ b r i n
degradation products (FDPs) 11.4µg·mL−1. aPTT, PT, elec-
trolytes, and serum creatinine levels were normal. Transtho-
racic echocardiography showed a 13mm VSD with promi-
nent right-to-left shunt, dilated right atrium (55mm)
and right ventricle (48mm), right ventricular hypertro-
phy (12mm), moderate-to-severe tricuspid regurgitation,2 Anesthesiology Research and Practice
estimated systolic pulmonary artery pressure of 107mmHg,
and an estimated left ventricular ejection fraction (EF) of
74%. Uterine ultrasonography showed IUGR.
The patient was transferred to the intensive care unit
(ICU) and treated by a multidisciplinary team of obste-
tricians, cardiologists, and anaesthesiologists. She received
oxygen by facemask with bed rest in the left lateral
decubitus position. Dexamethasone 6mg was given to
accelerate fetal lung maturity. In view of her hypoxemic
condition and IUGR, a caesarean section was scheduled
and metoclopramide and ranitidine were used as aspiration
prophylaxis. Upon arrival in the operating room, RR was
21 breaths·min−1,H R9 9b e a t s ·min−1, BP 120/53mmHg,
and SpO2 77% on 100% oxygen. General anaesthesia was
chosen due to thrombocytopenia. The patient was mon-
itored with electrocardiography, pulse oximetry, and end-
tidal capnography, and noninvasive BP and left uterine
displacement was applied by a 15◦ left-tilt of the operation
table.Asrapidsequenceinduction(RSI)withpredetermined
dose of anesthetics may be either excessive or inadequate,
RSI was not performed after we weighed the risks of
aspiration against hemodynamic instability. Slow induction
of general anesthesia with titrate-to-eﬀect etomidate 10mg
wasusedtoavoiddramatichemodynamicﬂuctuations.Intu-
bation was facilitated with atracurium 30mg. Atracurium
was chosen to avoid further exacerbation of the com-
promised liver function. Anaesthesia was maintained with
sevoﬂurane (1-2% end-tidal concentration) in oxygen and
remifentanil infusion at the rate of 0.08–0.10µg·kg−1 min−1.
BP and heart rate were stable (94–123/40–67mmHg, 79–
120beats·min−1) during the 45-minute operation, and SpO2
remained 67%–76% throughout the uneventful procedure.
A female baby was delivered with Apgar scores of 8 at
1min, 9 at 5min, and 10 at 10min. Estimated blood loss
was 100mL, and ﬂuid administration was 550mL Lactated
Ringer’s solution. Urine output was 200mL. The patient
was extubated in the operating room, and vital signs in
the ICU showed BP 138/88mmHg, HR 100 beats·min−1,
RR 26 breaths·min−1,a n dS pO2 66%. Blood gas analysis
demonstrated PaCO2 36mmHg, PaO2 41mmHg, and SaO2
72%. She received transfusion of fresh frozen plasma and
platelets in the ICU. Intravenous morphine 3–5mg was
administered by nurse when necessary (nurse-controlled
analgesia). The patient was reintubated due to severe hypox-
emia 2 hours following extubation. On the 1st and 2nd
postoperative days (PODs), her BP and HR were stable
with administration of 0.2–0.5µg·kg−1·min−1 nitroglycerin,
while SpO2 remained in the range of 62%–74%. On the
3rd POD, her SpO2 acutely decreased to 42%, and she
became unarousable. Despite aggressive resuscitative eﬀorts,
she died two hours later. Postmortem examination was
denied.
2.2. Case 2. A 30-year-old woman (G2P1, weight 62kg,
height 162cm) with a 33-week gestation had dizziness,
fatigue, dyspnea, and lower extremity edema for 1 week. She
was diagnosed with congenital heart disease 10 years ago but
remained asymptomatic without therapy until this time. She
deliveredafemalebabybycaesareansectionwithoutincident
atanotherhospital6yearsago.Therewasnoothersigniﬁcant
past medical history. Vital signs were HR 84 beats·min−1,
RR 20 breaths·min−1, BP 125/80mmHg, and SpO2 58%
on room air and 75%–88% on oxygen at 6L·min−1 by
facemask. She had marked cyanosis and clubbing of her
ﬁngers. Auscultation revealed a loud P2 and a grade 5/6
systolic murmur in the pulmonary area. There was moderate
lower extremity edema. Laboratory test results included
Hb 14.5g·dL−1, Hct 45%, platelets 173 × 109·L−1,A L T
271g·L−1, AST 184g·L−1, albumin 3.52g·dL−1, and normal
PT and aPTT. Blood gases showed pH 7.35, PaO2 61mmHg,
PaCO2 34mmHg, HCO
−
3 18.1mmol·L−1, base excess (BE)
−6.6, and SaO2 90.1%. Transthoracic echocardiography
revealed a 20mm VSD with bidirectional blood ﬂow at rest,
enlarged left ventricle (54mm), mild dilation of the right
atrium, hypertrophy of the right ventricle, mild tricuspid
regurgitation, estimated systolic pulmonary artery pressure
of 166mmHg, mild pericardial eﬀusion, and an estimated
left ventricular EF of 61%.
After admission to the ICU, she was managed by a
multidisciplinary team of obstetricians, cardiologists, and
anaesthesiologists. She received oxygen by facemask with
bed rest in the left lateral decubitus position. After 3 days
of observation, a caesarean section was performed under
epidural anesthesia. Left uterine displacement was applied
by a 15◦ left-tilt of the operation table, and a radial
arterial line and a central venous catheter were inserted.
Initial BP was 149/71mmHg, central venous pressure (CVP)
10cmH2O, HR 82 beats·min−1,a n dS pO2 87%. An epidural
catheter was inserted at the L1-L2 intervertebral space on left
lateral decubitus position. Incremental doses of 3–5mL of
2% lidocaine without epinephrine were administered every
5min, and a sensory block to the level of T6 was achieved
with 21mL lidocaine over a 30min period. The sensory
blockadelevelwasintendedlykeptnohigherthanT6 toavoid
signiﬁcant hemodynamic changes. The surgery proceeded
uneventfully without any pain or discomfort. Throughout
the procedure, CVP was maintained at 10–12cmH2O.
Invasive BP was 150/70mmHg before delivery, but abruptly
decreased to 110/56mmHg with delivery and responded to
norepinephrine infusion at 0.05–0.08µg·kg−1·min−1. Blood
gas analysis showed PaO2 170mmHg, PaCO2 36mmHg,
SaO2 99.7%, Hb 12.6g·dL−1, and Hct 38%. Apgar scores
were 9 at 1min and 10 at 5min. After delivery, tubal
ligation was performed. Intraoperative ﬂuid therapy was
guided by BP, HR, and CVP, and a total of 400mL Ringer’s
solution was administered during the 108-minute surgery.
Estimated blood loss was 200mL. Urine volume was 200mL.
PCEA of 0.2% ropivacaine was started with a background
dose of 4mL·hour−1 for analgesia. Epidural opioid was
not administered to avoid the adverse eﬀects of respiratory
depression, which can be disastrous in these patients. After
surgery, the patient was monitored in the ICU for 2 days
before transfer to the obstetric ward. Her condition was
improving, and SpO2 was 93% on oxygen at 6L·min−1.O n
the 5th POD, she had a syncopal episode after walking to
the toilet. No other signiﬁcant postoperative complications
occurred. Both the mother and baby were doing well 6
months later.Anesthesiology Research and Practice 3
3. Discussion
Pregnancy-induced systemic vasodilation is detrimental in
parturients with Eisenmenger’s syndrome. Reduced SVR
may increase right-to-left shunting and decrease pulmonary
blood ﬂow, leading to further hypoxemia with signiﬁcant
risks for both mother and fetus. Anaesthetic management
of caesarean section in parturients with Eisenmenger’s
syndrome requires balancing SVR and pulmonary vascular
resistance (PVR).
General anaesthesia is often used for emergency cae-
sarean section. However, positive pressure ventilation may
decrease venous return and systemic blood pressure, which
can increase the right-to-left shunting. In our hospital,
general anaesthesia is used when there are contraindications
to neuraxial anaesthesia or in cases of life-threatening
emergency with inadequate time for neuraxial anaesthesia.
The parturient in our ﬁrst case had thrombocytopenia.
Intravenous etomidate was used for induction to minimize
the risks of decreased SVR and cardiac depression. For main-
tenance of anaesthesia, nitrous oxide was avoided because
it is a potent pulmonary vasoconstrictor. Remifentanil can
be used to produce stable hemodynamics without subse-
quent neonatal depression [4]. Maternal mortality remains
increased in the ﬁrst three to four weeks after delivery, so
prolonged postoperative care in an intensive care unit setting
may be needed [5].
Neuraxial anaesthesia has the advantage of avoiding
myocardial depression, but the risk of excessively decreased
SVR due to the existence of sympathetic blockade, especially
with single-shot spinal anaesthesia. In our second case,
small boluses of 2% lidocaine were used to produce a T6
block without signiﬁcant circulatory changes. Epinephrine
should be avoided because it can produce tachycardia and
arrhythmias, which will increase myocardial oxygen demand
and be poorly tolerated in Eisenmenger’s syndrome [6].
For patients with Eisenmenger’s syndrome, the level of
sensory blockade involves a balance between safety and
comfort. We kept the sensory blockade level no higher than
T6, and we think may be it is better than the traditional T4
level which can cause dangerous bradycardia with blockade
of sympathetic cardioaccelerator ﬁbres in these high-risk
patients. A review of 57 articles involving 103 patients
showed the safety of regional anaesthesia and recommended
its use in Eisenmenger’s syndrome [7]. Hemodynamic and
respiratory changes are usually minimal with well-managed
epidural anaesthesia. However, meta-analysis does not show
a signiﬁcant diﬀerence in perioperative mortality between
general and regional anaesthesia, and both approaches
have signiﬁcant morbidity and mortality [8]. The choice
of general versus epidural-spinal anaesthesia should be
made after considering the patient’s unique physiology and
with consultation with cardiologists, obstetricians, obstetric
anaesthesiologists, and cardiac anaesthesiologists.
Vigilant intraoperative monitoring is essential for these
patients. Pulse oximetry is the simplest way to assess the deg-
ree of right-to-left shunt. Invasive arterial blood pressure
andCVPmonitoringarerecommended.Becausebloodpres-
sure is often a poor indication of tissue perfusion, monito-
ring of cardiac output may be needed. The usefulness of
a pulmonary artery catheter is controversial in patients
with Eisenmenger’s syndrome. Transesophageal echocardio-
graphy can provide information about cardiac function
and intracardiac shunting, but it may not be tolerated in
conscious patients. In our second case, continuous arterial
and CVP monitoring were valuable in guiding ﬂuid therapy
and infusion of vasopressors during operation.
Titrated perioperative ﬂuid therapy is critical in patients
with Eisenmenger’s syndrome. Eﬀorts should be made
to avoid intravascular hypovolemia from prolonged fast-
ing with consequent dehydration. Sympathectomy-mediated
vasodilatation with neuraxial anaesthesia can produce
hypotension, so volume expansion and vasopressors should
be provided immediately. The use of uterine displacement
promotes venous return to the heart. However, excessive
ﬂuid administration can overwhelm the compromised right
heart. CVP monitoring wasindicated in our caseto maintain
constant ﬁlling pressures in the perioperative period.
Management of patients with Eisenmenger’s syndrome
mayincludetheuseofsupplementaloxygen,digitalis,diuret-
ics, vasodilators, and anticoagulants. Supplementary oxygen
for elective and emergency caesarean section is controversial
for healthy patients [9]. In patients with Eisenmenger’s syn-
drome, oxygen is a pulmonary vasodilator which decreases
the blood ﬂow across the right-to-left shunt and thereby
improves oxygen saturation, so it should be considered for
patients with Eisenmenger’s syndrome throughout the peri-
operative period. Maternal arterial oxygen tension should be
maintained at 70mmHg or above when possible. One must
be careful in using digitalis with diuretics in patients who are
hypoxemic as there is an increased risk of digitalis toxicity.
Diuretics may be useful for patients with Eisenmenger’s syn-
drome and severe right heart failure in order to relieve hep-
atic congestion or increased intravascular volume. This must
be done cautiously to avoid decreasing preload below that
required to maintain adequate cardiac output with increased
right ventricular afterload. Because of possible teratogenic-
ity and adverse eﬀects on uterine circulation, pulmonary
vasodilators including prostacycline analogs (Epoprostenol,
Treprostinil, Beraprost, and Iloprost), phosphodiesterase
inhibitors (Sildenaﬁl, Tadalaﬁl), endothelin receptor antag-
onists (Bosentan, Sitaxsentan, and Ambrisentan) are not
recommended in pregnancy [10]. Use of inhaled nitric
oxide during labor has been recommended in Eisenmenger’s
syndrome. However, it was not available at the time in our
hospital. In addition, for patients with severe polycythemia,
one needs to consider the danger of increased hyperviscosity,
which can lead to stroke and other related complications.
The role of anticoagulation in Eisenmenger’s syndrome
is controversial. Pregnancy represents a hypercoagulable
state, and evidence suggests pulmonary thromboembolism
as a cause for maternal demise. However, adverse outcome
has been associated with prophylactic heparin therapy in
parturients with Eisenmenger’s syndrome. Judicious use of
antithrombotic drugs and early ambulation may increase
survival in patients with Eisenmenger’s syndrome. We
did not use anticoagulation in the ﬁrst case because of
the high risk of hemorrhage with thrombocytopenia and4 Anesthesiology Research and Practice
coagulopathy. The cause of death was discussed by the
multidisciplinary team, and pulmonary embolism was a
suspected cause of death. Autopsy was suggested to get the
deﬁnite cause of death, however, it was denied by the family
of the patient.
In summary, patients with Eisenmenger’s syndrome
undergoing caesarean section present many anaesthetic chal-
lenges, but an understanding of the underlying physiology
and the use of a multidisciplinary team can guide anaesthetic
management.
Consent
This paper is published with the consent of the patients and
their families.
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